FAP and neoplasm: Fibroblast Activation Protein (FAP)-targeted RLT agents bind FAP, a transmembrane serine protease selectively expressed on cancer-associated fibroblasts, which are present in the tumour microenvironment of approximately 90% of solid tumours.